Advertisement
For key demographic subgroups of patients with acute ischemic stroke

Low-Dose Alteplase No Better for Acute Ischemic Stroke

0
No differences between low, standard dose in treatment effects for poor outcomes by age, ethnicity
In an effort to halt the ongoing opioid addiction crisis

Opioid Manufacturers to Provide Doctor Training

0
74 manufacturers of immediate-release opioids notified that drugs will be subject to requirements
Long-term use of azathioprine is associated with a better disease course in patients with early Crohn's disease

Azathioprine Appears to Improve Disease Course in Early Crohn’s

0
Prior bowel resection, smoking, and low hemoglobin tied to Crohn's-related surgery
In Washington state

Legal Cannabis Use Common Among Cancer Patients

0
Legalization increases likelihood of use; most want information about the drug from their doctors

September 2017 Briefing – Pharmacy

0
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for September 2017. This roundup includes the latest...
Secukinumab is safe and effective as a treatment for patients with extensive moderate-to-severe scalp psoriasis

Secukinumab Effective for Moderate/Severe Scalp Psoriasis

0
Over half of patients have 90 percent improvement on Psoriasis Scalp Severity Index score
Pioglitazone improves whole-body and myocardial insulin sensitivity

Pioglitazone Improves Left Ventricular Diastolic Function

0
Both whole-body and myocardial insulin sensitivity improved in type 2 diabetes patients
A Vi-tetanus toxoid conjugate vaccine is efficacious for prevention of typhoid fever

Vi-Tetanus Toxoid Conjugate Vaccine Can Prevent Typhoid

0
Vaccine efficacy was 54.6 percent for Vi-conjugate in human infection model of Salmonella Typhi
Dietary supplementation does not lead to measurable increases in macular pigment optical density

Supplements Don’t Measurably Increase Macular Pigment Density

0
In offspring of macular degeneration patients, lutein plus zeaxanthin does not lead to density change
Immune-related adverse events

Checkpoint Inhibitors No Less Safe With Radiation

0
Combination does not increase immune-related adverse events in metastatic lung cancer patients